IOSAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Iosat, and when can generic versions of Iosat launch?
Iosat is a drug marketed by Anbex and is included in one NDA.
The generic ingredient in IOSAT is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iosat
A generic version of IOSAT was approved as potassium iodide by MISSION PHARMACAL on March 24th, 2016.
Summary for IOSAT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 212 |
Patent Applications: | 3,503 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in IOSAT? | IOSAT excipients list |
DailyMed Link: | IOSAT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for IOSAT
US Patents and Regulatory Information for IOSAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anbex | IOSAT | potassium iodide | TABLET;ORAL | 018664-002 | May 12, 2011 | OTC | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Anbex | IOSAT | potassium iodide | TABLET;ORAL | 018664-001 | Oct 14, 1982 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |